ASSOCIATION OF ALTERATIONS IN NF-KAPPA-B MOIETIES WITH HIV TYPE-1 PROVIRAL LATENCY IN CERTAIN MONOCYTIC CELLS

被引:15
作者
OAKES, JW [1 ]
BAGASRA, O [1 ]
DUAN, LX [1 ]
POMERANTZ, RJ [1 ]
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,DIV INFECT DIS,MOLEC RETROVIROL SECT,PHILADELPHIA,PA 19104
关键词
D O I
10.1089/aid.1994.10.1213
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) replication is controlled by a complex array of virally encoded and cellular proteins. A wide spectrum of levels of HIV-1 expression have been demonstrated in various cells, both in cell culture and in vivo. Molecular mechanisms leading to restricted HIV-1 replication may differ between certain cell types. It is now demonstrated that HIV-1 proviral latency in the monocytic cell line U1, in which only extremely low levels of HIV-1 expression are detected in the baseline unstimulated state, is associated with alterations in nuclear factor-kappa B (NF-kappa B) moieties demonstrated in these cells by electrophoretic mobility shift assays (EMSAs) and in situ UV cross-linking studies. A predominance of p50 NF-kappa B moieties and possibly p50 homodimers or closely related species, rather than the p50-p56 heterodimer of NF-kappa B that is the predominant NF-kappa B species in most T lymphocytic and monocytic cells, is demonstrated in the nuclei of U1 cells. This pattern of NF-kappa B-related moieties differs from the latently infected T lymphocytic cell line ACH-2, and from the U937 monocytic line, the parental cell line of the U1 cellular clone. As such, these data suggest that different proximal mechanisms may lead to restricted HIV-1 replication in various cell types.
引用
收藏
页码:1213 / 1219
页数:7
相关论文
共 31 条
[1]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[2]   CD14 IS INVOLVED IN CONTROL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION IN LATENTLY INFECTED-CELLS BY LIPOPOLYSACCHARIDE [J].
BAGASRA, O ;
WRIGHT, SD ;
SESHAMMA, T ;
OAKES, JW ;
POMERANTZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6285-6289
[3]   THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION [J].
BALLARD, DW ;
WALKER, WH ;
DOERRE, S ;
SISTA, P ;
MOLITOR, JA ;
DIXON, EP ;
PEFFER, NJ ;
HANNINK, M ;
GREENE, WC .
CELL, 1990, 63 (04) :803-814
[4]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431
[5]   REGULATION OF TUMOR NECROSIS FACTOR-ALPHA TRANSCRIPTION IN MACROPHAGES - INVOLVEMENT OF 4 KAPPA-B-LIKE MOTIFS AND OF CONSTITUTIVE AND INDUCIBLE FORMS OF NF-KAPPA-B [J].
COLLART, MA ;
BAEUERLE, P ;
VASSALLI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1498-1506
[6]   IN-VIVO FOOTPRINTING ANALYSIS OF CONSTITUTIVE AND INDUCIBLE PROTEIN-DNA INTERACTIONS AT THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DEMARCHI, F ;
DAGARO, P ;
FALASCHI, A ;
GIACCA, M .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7450-7460
[7]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[8]   TAT AND REV DIFFERENTIALLY AFFECT RESTRICTED REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I IN VARIOUS CELLS [J].
DUAN, LX ;
OAKES, JW ;
FERRARO, A ;
BAGASRA, O ;
POMERANTZ, RJ .
VIROLOGY, 1994, 199 (02) :474-478
[9]   TUMOR NECROSIS FACTOR A ACTIVATES HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 THROUGH INDUCTION OF NUCLEAR FACTOR BINDING TO THE NF-KAPPA-B SITES IN THE LONG TERMINAL REPEAT [J].
DUH, EJ ;
MAURY, WJ ;
FOLKS, TM ;
FAUCI, AS ;
RABSON, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5974-5978
[10]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362